House Bill 2417, aimed at bolstering Oregon's bioscience sector, received strong support during a recent meeting of the House Committee on Economic Development, Small Business, and Trade. Key advocates from the industry highlighted the significant economic impact and job creation potential of the bioscience ecosystem in the state.

Steven H. from Genentech emphasized the company's long-standing commitment to Oregon, noting their substantial investments in local facilities and the creation of nearly 900 jobs. He pointed out that Genentech's presence is part of a thriving bioscience ecosystem, which has seen considerable growth since the company's initial investment in 2006. "The investment in Otradi has paid off and it will continue to do so," he stated, urging continued support for the sector amidst federal funding uncertainties.

Caitlin Vargas, vice president of Collaborative Economic Development Oregon, echoed these sentiments, sharing insights on Lane County's emerging bioscience industry. With 90 bioscience companies employing over 1,400 people at an average wage significantly higher than the county average, Vargas highlighted the need for greater access to capital to sustain and grow these businesses. "These companies have the potential to reshape Lane County's economic identity just as Nike once did," she remarked, underscoring the importance of local innovation and support systems.

Both speakers called for strategic collaboration and investment to address existing gaps in the bioscience ecosystem, ensuring that Oregon remains a competitive player in the industry. As the state continues to cultivate its bioscience sector, the discussions at this meeting signal a commitment to fostering economic growth and innovation in Oregon.